These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24812044)

  • 61. Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
    Anderson J; Bell C; Bishop J; Capila I; Ganguly T; Glajch J; Iyer M; Kaundinya G; Lansing J; Pradines J; Prescott J; Cohen BA; Kantor D; Sachleben R
    J Neurol Sci; 2015 Dec; 359(1-2):24-34. PubMed ID: 26671082
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnosis and disease modifying treatments in multiple sclerosis.
    Zajicek J
    Postgrad Med J; 2005 Sep; 81(959):556-61. PubMed ID: 16143683
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
    Correale J; Cristiano E
    Medicina (B Aires); 2001; 61(4):470-80. PubMed ID: 11563177
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [An effect of disease-modifying drugs on the development of children born to mothers with multiple sclerosis].
    Kasatkin DS; Spirin NN; Vinogradova TV; Shytova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):85-91. PubMed ID: 28617366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Unmasking autoimmune hepatitis under immunomodulatory treatment of multiple sclerosis--not only beta interferon.
    von Kalckreuth V; Lohse AW; Schramm C
    Am J Gastroenterol; 2008 Aug; 103(8):2147-8; author reply 2148. PubMed ID: 18796115
    [No Abstract]   [Full Text] [Related]  

  • 66. [Immunomodulatory effects of glatiramer acetate as they relate to stage-specific immune dysregulation in multiple sclerosis].
    Yokoyama K; Hattori N
    Nihon Yakurigaku Zasshi; 2016 Aug; 148(2):105-20. PubMed ID: 27478050
    [No Abstract]   [Full Text] [Related]  

  • 67. [Esclerosis multiple. Lactancia. Lactante. Planificacion familiar. Posparto. Tratamiento modificador de la enfermedad.].
    Sánchez-Velasco S; Midaglia L; Vidal-Jordana A; Castillo F; Horno R; Carreras E; Serrano B; Bosch M; Agustí A; Montalban X; Tintoré M
    Rev Neurol; 2023 Jan; 76(1):21-30. PubMed ID: 36544373
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiple sclerosis: the role of melatonin and N-acetylserotonin.
    Anderson G; Rodriguez M
    Mult Scler Relat Disord; 2015 Mar; 4(2):112-23. PubMed ID: 25787187
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis.
    Sternberg Z; Leung C; Sternberg D; Yu J; Hojnacki D
    Cardiovasc Ther; 2014 Apr; 32(2):33-9. PubMed ID: 24119301
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
    Costello K
    J Neurosci Nurs; 2013 Dec; 45(6 Suppl 1):S14-23. PubMed ID: 24217187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Multiple sclerosis and pregnancy].
    Ruuskanen J; Malm H; Airas L
    Duodecim; 2013; 129(14):1457-64. PubMed ID: 23961604
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
    Goodin DS; Bates D
    Mult Scler; 2009 Oct; 15(10):1175-82. PubMed ID: 19737851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
    Bonafede MM; Johnson BH; Wenten M; Watson C
    Clin Ther; 2013 Oct; 35(10):1501-12. PubMed ID: 24139422
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis.
    Yeh EA; Waubant E; Krupp LB; Ness J; Chitnis T; Kuntz N; Ramanathan M; Belman A; Chabas D; Gorman MP; Rodriguez M; Rinker JR; Weinstock-Guttman B;
    Arch Neurol; 2011 Apr; 68(4):437-44. PubMed ID: 21149803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [New approaches in research of therapy of multiple sclerosis].
    Hemmer B; Cepok S; Nessler S; Sommer N
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():23-8. PubMed ID: 11603112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
    Ehling R; Di Pauli F; Lackner P; Rainer C; Kraus V; Hegen H; Lutterotti A; Kuenz B; De Zordo T; Schocke M; Glatzl S; Löscher WN; Deisenhammer F; Reindl M; Berger T
    J Neuroimmunol; 2015 Oct; 287():98-105. PubMed ID: 26439969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.
    He A; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Lugaresi A; Izquierdo G; Grammond P; Duquette P; Girard M; Pucci E; Iuliano G; Alroughani R; Oreja-Guevara C; Fernandez-Bolaños R; Grand'Maison F; Sola P; Spitaleri D; Granella F; Terzi M; Lechner-Scott J; Van Pesch V; Hupperts R; Sánchez-Menoyo JL; Hodgkinson S; Rozsa C; Verheul F; Butzkueven H; Kalincik T;
    JAMA Neurol; 2015 Apr; 72(4):405-13. PubMed ID: 25665031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugs.
    Reynolds MW; Stephen R; Seaman C; Rajagopalan K
    J Med Econ; 2010 Mar; 13(1):90-8. PubMed ID: 20078189
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 'Time is brain' also in multiple sclerosis.
    Freedman MS
    Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
    [No Abstract]   [Full Text] [Related]  

  • 80. Strategies for managing the side effects of treatments for multiple sclerosis.
    Langer-Gould A; Moses HH; Murray TJ
    Neurology; 2004 Dec; 63(11 Suppl 5):S35-41. PubMed ID: 15596735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.